RCGE yields 1.84% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 7
Combined, RCGE + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RCGE + JNJ for your $10,000?
RCGE is actively managed to provide exposure to a portfolio of companies committed to managing their organizations with a gender-balance approach. The eligible universe starts from the largest 3,000 stocks by market cap in developed markets, and the largest 1,000 stocks by market-cap in emerging markets. The fund filters stocks by looking at a companys gender equality score, which is based on gender balance, gender pay gap, and policies relating to parental leave and sexual harassment. Companies in which a score cannot be determined are excluded. An additional ethics screen is used to further narrow down the eligible universe. Lastly, the fund will look at a companys financial performance, mainly debt-to-equity ratio, debt-to EBITDA, and financial statement strength. The top 150 to 200 companies with the highest gender score that meet the financial criteria are selected. The fund imposes individual, countries, and sector caps. Rebalancing is done quarterly.
Full RCGE Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.